Source: The Chase Group Blog

The Chase Group Blog Arcturus Retains The Chase Group to Expand Vaccine Development Programs

As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100